Johnson & Johnson (JNJ) FY2025 Q1 Balance Sheet

Johnson & Johnson (JNJ) FY2025 Q1 Balance Sheet

Balance sheet as of 2025-03-30. The chart shows assets, liabilities and equity at that date.

Assets

193,671,000,000 US dollars

Current assets

71,551,000,000 US dollars

Non-current assets

122,120,000,000 US dollars

Liabilities

115,562,000,000 US dollars

Current liabilities

56,903,000,000 US dollars

Non-current liabilities

58,659,000,000 US dollars

Equity

78,109,000,000 US dollars

Property, plant and equipment at cost

49,884,000,000 US dollars. Part of Property, plant and equipment, net, drawn as one net amount.

Less: accumulated depreciation

negative 29,013,000,000 US dollars. Part of Property, plant and equipment, net, drawn as one net amount.

Cash and cash equivalents (Note 4)

38,474,000,000 US dollars

Accounts receivable, trade, less allowances $170 (2024, $167)

16,020,000,000 US dollars

Inventories (Note 2)

12,659,000,000 US dollars

Prepaid expenses and other

4,091,000,000 US dollars

Marketable securities

307,000,000 US dollars

Goodwill (Note 3)

44,468,000,000 US dollars

Intangible assets, net (Note 3)

36,755,000,000 US dollars

Property, plant and equipment, net

20,871,000,000 US dollars

Other assets

11,534,000,000 US dollars

Deferred taxes on income (Note 5)

8,492,000,000 US dollars

Accrued rebates, returns and promotions

18,780,000,000 US dollars

Loans and notes payable

13,897,000,000 US dollars

Accounts payable

9,545,000,000 US dollars

Accrued liabilities

7,913,000,000 US dollars

Accrued taxes on income (Note 5)

4,217,000,000 US dollars

Accrued compensation and employee related obligations

2,551,000,000 US dollars

Long-term debt (Note 4)

38,355,000,000 US dollars

Other liabilities

10,435,000,000 US dollars

Employee related obligations (Note 6)

7,046,000,000 US dollars

Deferred taxes on income (Note 5)

2,428,000,000 US dollars

Long-term taxes payable (Note 5)

395,000,000 US dollars

Retained earnings and Additional paid-in capital

162,635,000,000 US dollars

Common stock — par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)

3,120,000,000 US dollars

Less: common stock held in treasury, at cost (714,218,000 and 712,921,000 shares)

negative 75,906,000,000 US dollars

Accumulated other comprehensive income (loss) (Note 7)

negative 11,740,000,000 US dollars

Gross equity (calculated)

165,755,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.